Mirum Pharmaceuticals, Inc. (MIRM)

Last Closing Price: 95.51 (2026-11-19)

Long-Term Liabilities (Quarterly)

Long-Term Liabilities: The sum of all non-current liabilities.

Mirum Pharmaceuticals, Inc. (MIRM) had Long-Term Liabilities of $797.72M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$185.72M
$-40.77M
$35.17M
$150.55M
$245.47M
$-59.75M
$19.52M
$-40.23M
$-40.23M
$-40.77M
$-40.77M
$-40.77M
$-40.77M
$-59.75M
$-52.01M
65.53M
66.05M
$-0.62
$-0.87
Balance Sheet Financials
$586.63M
$3.25M
$439.98M
$1.03B
$283.08M
$731.25M
Long-Term Liabilities
$797.72M
$1.08B
$-54.19M
$-329.83M
$-54.19M
65.21M
Cash Flow Statement Financials
$-277.33M
$-200.43M
$427.17M
$298.17M
$244.92M
$-53.24M
$100.08M
--
--
Fundamental Metrics & Ratios
2.07
--
--
1.08
-13.50
81.06%
-32.17%
-32.17%
--
-21.66%
-21.95%
$-279.32M
--
--
--
0.18
1.38
1.19
75.77
75.23%
12.36%
-3.97%
-6.02%
$-0.83
$-4.23
$-4.20